AclandG.M., AguirreG.D., RayJ.et al.2001. Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet., 28:92–95.
2.
AliR.R., ReichelM.B., ThrasherA.J.et al.1996. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum. Mol. Genet., 5:591–594.
3.
AliR.R., SarraG.M., StephensC.et al.2000. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat. Genet., 25:306–310.
BainbridgeJ.W., StephensC., ParsleyK.et al.2001. In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector: Efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther., 8:1665–1668.
6.
BainbridgeJ.W.B., SmithA.J., BarkerS.S.et al.2008. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med., 358:2231–2239.
7.
BennettJ., WilsonJ., SunD.et al.1994. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest. Ophthalmol. Vis. Sci., 35:2535–2542.
8.
DelgadoD., Del Pozo-RodríguezA., SolinísM.A.et al.2012. Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis. Hum. Gene Ther.(this issue).
9.
DinculescuA., EstreicherJ., ZentenoJ.C.et al.2012. Gene therapy for retinitis pigmentosa caused by MFRP mutations: Human phenotype and preliminary proof of concept. Hum. Gene Ther.(this issue).
10.
HauswirthW., AlemanT.S., KaushalS.et al.2008. Phase I trial of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: Short-term results. Hum. Gene Ther., 19:979–990.
11.
LiT., AdamianM., RoofD.J.et al.1994. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest. Ophthalmol. Vis. Sci., 35:2543–2549.
12.
MaguireA.M., SimonelliF., PierceE.A.et al.2008. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med., 358:2240–2248.
13.
MaoH., GorbatyukM.S., RossmillerB.et al.2012. Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice. Hum. Gene Ther.(this issue).
14.
Millington-WardS., ChaddertonN., O'ReillyM.et al.2011. Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa. Mol Ther, 19:642–649.
15.
SmithA.J., BainbridgeJ.W., AliR.R.2012. Gene supplementation therapy for recessive forms of inherited retinal dystrophies. Gene Ther., 19:154–161.
